Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15333 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Carl Johan Svensson and 4 co-authors. Institution: Department of Anaesthesiology and Intensive Care, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. Major MEDLINE topics: Graft Survival, Kidney Transplantation, Registries, Tissue Donors. 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background and aim Stress cardiomyopathy in donors can potentially affect graft function and longevity. This study aims to investigate the association between echocardiographic left ventricular ejection fraction (LVEF) < 50%, and/or the presence of left ventricular regional wall motion abnormalities (RWMA) in organ donors, and short‐ and long‐term liver and kidney graft survival. Our secondary aim was to link graft survival with donor and recipient characteristics.
Methods
All donors considered for liver and kidney donation with echocardiographic records at Sahlgrenska University Hospital between 2006 and 2016 were matched with their recipients through the Scandiatransplant register. The studied outcomes were graft survival, re‐transplantation, and recipient death. Kaplan–Meier curves were used to plot time to event. Multivariate Cox‐regression was used to test independence.
Results
There were 370 liver donors and 312 kidney donors (matched with 458 recipients) with echocardiographic records at Sahlgrenska University Hospital between June 2006 and November 2016. Of patients with LV dysfunction by echocardiography, there were 102 liver‐ and 72 kidney donors. Univariate survival analyses showed no statistical difference in the short‐ and long‐term graft survival from donors with LV dysfunction compared to donors without. Donor age > 65 years, recipient re‐transplantation and recipient liver tumor were predictors of worse outcome in liver transplants ( p < .05). Donor age > 65, donor hypertension, recipient re‐transplantation, and a recipient diagnosis of diabetes or nephritis/glomerulonephritis had a negative association with graft survival in kidney transplants ( p < .05).
Conclusion
We found no significant association between donor LV dysfunction and short‐ and long‐term graft survival in liver and kidney transplants, suggesting that livers and kidneys from such donors can be safely transplanted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Anaesthesiology and Intensive Care, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Anaesthesiology and Intensive Care Medicine, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Cardiothoracic Surgery, Transplant Institute, Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID profiles: Carl Johan Svensson
Cite
APA
Svensson, C. J., Öberg, J., Dellgren, G., Gäbel, M., & Oras, J. (2024). Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden. Clinical Transplantation. https://doi.org/10.1111/ctr.15333
Vancouver
Svensson CJ, Öberg J, Dellgren G, Gäbel M, Oras J. Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden. Clinical Transplantation. 2024. doi:10.1111/ctr.15333
BibTeX
@article{Svensson2024,
author = {Svensson, Carl Johan and Öberg, Josefin and Dellgren, Göran and Gäbel, Markus and Oras, Jonatan},
title = {Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15333}
}
EUVIMED